	Prognostic Significance of Up-to-Seven Criteria Versus Milan Criteria for Hepatocellular Carcinoma Patients Undergoing Resection or Locoregional Therapy: A Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev Remitha NPSI, Kusuma IKWA, Sasmana IGAP, Supadmanaba IGP, Sindhughosa DA, Mariadi IK. PMID: 41312914 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class B. Liver Int Sasaki R, Shimose S, Saeki I, Ito T, Takeuchi Y, Tani J, Tomonari T, Sasaki K, Kakizaki S, Hatanaka T, Miuma S, Shirono T, Iwamoto H, Tanabe N, Yamamoto T, Kanayama Y, Naganuma A, Nishina S, Takayama T, Kobara H, Otsuka M, Kawashima H, Takami T, Kawaguchi T, Miyaaki H, Hepatology InVestigator Experts in Japan (HIVE. PMID: 41312615 [PubMed - indexed for MEDLINE]
	Fibrinogen alpha and beta chains as non-invasive predictors of hepatocellular carcinoma progression. Sci Rep Kim HS, Choi JY, Jang SH, Kang M, Yoon MG, Baek GO, Park W, Han JE, Cho HJ, Jeong JY, Cheong JY, Kim SS, Eun JW. PMID: 41309856 [PubMed - indexed for MEDLINE]
	Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study. Lancet Oncol Qin S, Gu S, Chan SL, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Xu L, Yuan X, Li D, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Du J, Shi W, Cheng AL, Kaseb A, Vogel A, CARES-310 Study Group. PMID: 41308676 [PubMed - indexed for MEDLINE]
	Radioembolization in Hepatocellular Carcinoma: Indications and Outcomes. J Gastrointest Cancer Gholami B, Afrasiabi A, Varela P, Gholami S, Moon A, Villalobos A, Mauro D, Harris B, Yu H, Kokabi N. PMID: 41307819 [PubMed - indexed for MEDLINE]
	The impact of liver transection depth on surgical difficulty in robotic versus laparoscopic limited liver resection (TAKUMI-5). Langenbecks Arch Surg Fuji T, Takagi K, Yasui K, Ito A, Nishiyama T, Nagai Y, Yokoyama S, Fujiwara T. PMID: 41307730 [PubMed - indexed for MEDLINE]
	C-reactive protein flare: a promising prognostic predictor for patients with hepatocellular carcinoma treated with TACE combined with lenvatinib and immune checkpoint inhibitors. Front Immunol Li X, Chang X, Wu H, Han J, Wu C. PMID: 41306979 [PubMed - indexed for MEDLINE]
	Case Report: Long-term disease-free survival in an advanced hepatocellular carcinoma patient: an exceptional response to PD-1 inhibitor therapy. Front Immunol Fang Q, Yu S, Xiong Y, Zhang Y, Wang X, Zhou J, Wang F, Yin Z. PMID: 41306964 [PubMed - indexed for MEDLINE]
	Coriobacteriia may affect the occurrence of hepatocellular carcinoma through the pyrimidine, caffeine, urea cycle and glutamate metabolic pathways. Medicine (Baltimore) Dai J, Li Q, Chen J, Liu G, Dong Z, Ma Z, Luo Y. PMID: 41305817 [PubMed - indexed for MEDLINE]
	Prognostic impact of liver metastases on immunotherapy in patients with advanced solid tumors: A secondary analysis of MSK-IMPACT retrospective cohort. Medicine (Baltimore) Lin S, Yu X. PMID: 41305745 [PubMed - indexed for MEDLINE]
	Comparative Assessment of Point Shear Wave Elastography (pSWE) and Two-Dimensional Shear Wave Elastography (2D-SWE) in the Diagnostic Evaluation of Simple Liver Cysts and Liver Hemangiomas. Medicina (Kaunas) Nacheva-Georgieva EL, Doykov DI, Hristov BK, Stanchev DI, Todorov IS, Georgiev ZG, Doykova KA, Valova SE, Kraev KI, Uchikov PA. PMID: 41303777 [PubMed - indexed for MEDLINE]
	Epithelial to Mesenchymal Transition Transcriptional Regulator ZEB1 in Liver Cancer: Oncogenic Roles and Therapeutic Potential. Int J Mol Sci Gonzalez-Sanchez E, Roldan-Hernandez CA, Martin-Ramirez A, Garcia-Collado L, Fouassier L, Vaquero J. PMID: 41303618 [PubMed - indexed for MEDLINE]
	Integrating CTLA-4 Genetics and Soluble Isoforms for the Stratification of HCV-Related Hepatocellular Carcinoma Risk and Aggressiveness. Int J Mol Sci Hassan M, El-Maadawy WH, Fahim SA, Youssef SM, Badran OM, Balata M. PMID: 41303553 [PubMed - indexed for MEDLINE]
	Quercetin and Its Metabolites: Mechanistic Insights as the Basis of Their Therapeutic Potential in NAFLD and HCC. Molecules Li Z, Li Y, Jiang T, Wang Y, Li C, He Z. PMID: 41302497 [PubMed - indexed for MEDLINE]
	Differential Metabolic Dysregulations in Hepatocellular Carcinoma and Cirrhosis: Insights into Lipidomic Signatures. Biomolecules Ursu CP, Furcea LE, Procope, Ciocan RA, Ursu , Gherman CD, V, Pop RS, Moi, , Socaciu C, Al Hajjar N, Graur F. PMID: 41301494 [PubMed - indexed for MEDLINE]
	Qualitative and quantitative assessment of accelerated liver diffusion-weighted imaging using deep-learning reconstruction in oncologic patients. BMC Med Imaging Rata M, Castagnoli F, Shur J, Evans E, Hopkinson G, Benkert T, Weiland E, Koh DM, Winfield JM. PMID: 41299300 [PubMed - indexed for MEDLINE]
	Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma. Cancer Control Omar NE, Elewa H, El-Fass KA, Trapani D, Dermime S, Al-Badriyeh D, Abushanab D, Hamad A. PMID: 41297043 [PubMed - indexed for MEDLINE]
	Neuroendocrine Tumor of Unknown Primary Origin with Liver Metastasis Leading to Nonislet Cell Tumor Hypoglycemia. J Assoc Physicians India Suri T, Sinha N, Paliwal P. PMID: 41296294 [PubMed - indexed for MEDLINE]
	A comparative study of argon plasma coagulation and electrosurgical knife on postoperative complications after curative resection for hepatocellular carcinoma. Langenbecks Arch Surg Ye T, Yu R, Wu Y, Du J, Huang X, Hu H. PMID: 41296068 [PubMed - indexed for MEDLINE]
	The oncogenic role of BCL2L12 associated with immune status in the prognosis of human hepatocellular carcinoma. Naturwissenschaften Niu K, Cao S, Lian N, Du R, Lu G. PMID: 41296062 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 74468

Page 1 of 3724



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy